Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Dyne Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +11 vs. Q3 2023
- Shares held
- 69.9M
- +10.2M (+17.0%) vs. Q3 2023
- Total value
- $930.0M
- +$394.6M (+73.7%) vs. Q3 2023
- New holders
- 25
- 43 more added
- Sold out
- 14
- 40 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DYN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 245 | $4.23B |
| Q1 2026 | 228 | $3.40B |
| Q4 2025 | 233 | $3.48B |
| Q3 2025 | 207 | $1.97B |
| Q2 2025 | 198 | $1.22B |
| Q1 2025 | 205 | $1.29B |
| Q4 2024 | 200 | $2.63B |
| Q3 2024 | 200 | $4.03B |
| Q2 2024 | 193 | $3.92B |
| Q1 2024 | 169 | $2.71B |
| Q4 2023 | 124 | $930.0M |
| Q3 2023 | 114 | $536.6M |
| Q2 2023 | 118 | $665.9M |
| Q1 2023 | 127 | $628.7M |
| Q4 2022 | 113 | $576.2M |
| Q3 2022 | 102 | $565.8M |
| Q2 2022 | 90 | $320.7M |
| Q1 2022 | 94 | $456.6M |
| Q4 2021 | 93 | $568.3M |
| Q3 2021 | 83 | $572.8M |
| Q2 2021 | 76 | $753.4M |
| Q1 2021 | 75 | $533.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Dyne Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 824,000 | $11.0M | 0.29% | −376,000−31.3% | Reduced |
| Commodore Capital LP | 900,000 | $12.0M | 1.05% | +900,000 | New |
| Geode Capital Management, LLC | 932,838 | $12.4M | 0.00% | +75,128+8.8% | Added |
| Sofinnova Investments, Inc. | 1,013,505 | $13.5M | 0.76% | +328,372+47.9% | Added |
| Vivo Capital, LLC | 1,035,136 | $13.8M | 1.13% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,160,772 | $15.4M | 0.00% | −347,370−23.0% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,184,840 | $15.8M | 0.84% | +1,184,840 | New |
| Artal Group S.A. | 1,217,960 | $16.2M | 0.55% | +402,875+49.4% | Added |
| FMR LLC | 1,282,812 | $17.1M | 0.00% | +436,452+51.6% | Added |
| TCG Crossover Management, LLC | 1,650,150 | $21.9M | 2.43% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 1,684,517 | $22.4M | 0.12% | −3,285−0.2% | Reduced |
| Logos Global Management LP | 1,880,000 | $25.0M | 2.78% | −300,000−13.8% | Reduced |
| Franklin Resources Inc | 1,913,832 | $25.5M | 0.01% | +8760.0% | Added |
| Deep Track Capital, LP | 2,000,000 | $26.6M | 0.93% | −403,672−16.8% | Reduced |
| Morgan Stanley | 2,021,395 | $26.9M | 0.00% | +1,913,653+1,776.1% | Added |
| Vida Ventures Advisors, LLC | 2,074,787 | $27.6M | 32.85% | −145,247−6.5% | Reduced |
| VR Adviser, LLC | 2,173,913 | $28.9M | 1.98% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,329,641 | $31.0M | 0.00% | −34,673−1.5% | Reduced |
| State Street Corp | 2,337,141 | $31.1M | 0.00% | +398,499+20.6% | Added |
| Citadel Advisors LLC | 3,053,440 | $40.6M | 0.04% | +11,834+0.4% | Added |
| BlackRock Inc. | 3,788,682 | $50.4M | 0.00% | +481,717+14.6% | Added |
| MPM Asset Management LLC | 4,951,303 | $65.9M | 32.36% | 00.0% | Unchanged |
| FCPM III Services B.V. | 6,131,079 | $81.5M | 24.03% | +6,131,079 | New |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $131.5M | 15.66% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −315,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −280,276−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −184,010−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −24,400−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −24,326−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −22,052−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −20,938−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −19,926−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −17,646−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,644−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |